Driver Genes in Prostate Carcinogenesis and Resistance to Treatment
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".
Deadline for manuscript submissions: 25 February 2026 | Viewed by 12
Special Issue Editor
Interests: gene; tumor progression and metastasis and the modulation by bioactive lipids; cancer drug resistance; aberrant mTOR signaling in cancer cells and targets of intervention
Special Issue Information
Dear Colleagues,
Genomic instability is one of the hallmarks for prostate cancers, with many alternations documented in cancer genome sequencing projects including The Cancer Genome Atlas. Cataloging genetic mutations and other alternations in prostate cancers enhances the ability to discern driver genes for prostate carcinogenesis. This Special Issue aims to identify and discuss possible driver genes for prostate tumor initiation, progression, and resistance to castration therapy and other treatments. It particularly focuses on driver genes that can be amended via drugs or other interventions to improve prostate cancer prevention and treatment.
Prof. Dr. Daotai Nie
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genomic instability
- driver genes
- prostate cancer prevention
- castration therapy
- drug resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
